<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" article-type="brief-report">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">Emerg Infect Dis</journal-id>
      <journal-id journal-id-type="publisher-id">EID</journal-id>
      <journal-title-group>
        <journal-title>Emerging Infectious Diseases</journal-title>
      </journal-title-group>
      <issn pub-type="ppub">1080-6040</issn>
      <issn pub-type="epub">1080-6059</issn>
      <publisher>
        <publisher-name>Centers for Disease Control and Prevention</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">15200867</article-id>
      <article-id pub-id-type="pmc">3323076</article-id>
      <article-id pub-id-type="publisher-id">03-0416</article-id>
      <article-id pub-id-type="doi">10.3201/eid1004.030416</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Dispatch</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Human Case of Lobomycosis</article-title>
        <alt-title alt-title-type="running-head">Human Case of Lobomycosis</alt-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" corresp="yes">
          <name>
            <surname>Elsayed</surname>
            <given-names>Sameer</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">*</xref>
          <xref ref-type="aff" rid="aff2">&#x2020;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kuhn</surname>
            <given-names>Susan M.</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">&#x2020;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Barber</surname>
            <given-names>Duane</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">*</xref>
          <xref ref-type="aff" rid="aff2">&#x2020;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Church</surname>
            <given-names>Deirdre L.</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">*</xref>
          <xref ref-type="aff" rid="aff2">&#x2020;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Adams</surname>
            <given-names>Stewart</given-names>
          </name>
          <xref ref-type="aff" rid="aff3">&#x2021;</xref>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Kasper</surname>
            <given-names>Richard</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">*</xref>
          <xref ref-type="aff" rid="aff2">&#x2020;</xref>
        </contrib>
        <aff id="aff1"><label>*</label>Calgary Laboratory Services, Calgary, Alberta, Canada</aff>
        <aff id="aff2"><label>&#x2020;</label>University of Calgary, Calgary, Alberta, Canada</aff>
        <aff id="aff3"><label>&#x2021;</label>Calgary Health Region, Calgary, Alberta, Canada</aff>
      </contrib-group>
      <author-notes>
        <corresp id="cor1">Address for correspondence: Sameer Elsayed, Division of Microbiology, Calgary Laboratory Services, 1638-10th Avenue SW, Calgary, Alberta, T3C 0J5 Canada; fax: 403-209-5347; email: <email xlink:href="sameer.elsayed@cls.ab.ca">sameer.elsayed@cls.ab.ca</email></corresp>
      </author-notes>
      <pub-date pub-type="ppub">
        <month>4</month>
        <year>2004</year>
      </pub-date>
      <volume>10</volume>
      <issue>4</issue>
      <fpage>715</fpage>
      <lpage>718</lpage>
      <abstract>
        <p>We describe a 42-year-old woman with histologically confirmed lobomycosis, a cutaneous fungal infection rarely reported outside of Latin America. Our case represents the first published report of imported human lobomycosis in Canada and the fifth in an industrialized country.</p>
      </abstract>
      <kwd-group kwd-group-type="author">
        <title>Keywords: </title>
        <kwd>Lobomycosis</kwd>
        <kwd>Lobo&#x2019;s disease</kwd>
        <kwd>Loboa loboi</kwd>
        <kwd>Lacazia loboi</kwd>
        <kwd>infection</kwd>
        <kwd>human</kwd>
        <kwd>keloidal blastomycosis</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <p>In February 2001, a healthy, 42-year-old, female geologist from Canada came to her dermatologist with a slowly growing, 1.5-cm diameter, dusky-red, nontender, plaque-like lesion surrounded by keloidal scar tissue on the posterior aspect of her right upper arm (<xref ref-type="fig" rid="F1">Figure 1</xref>). It was located at the site of a scar from a previous excision attempt of a similar lesion 2 years earlier. The original lesion was first noticed while the patient was visiting Southeast Asia in 1996, although she did not seek medical attention until returning to Canada 1 year later. At that time, coccidioidomycosis was diagnosed based on her history of previous travel to a lobomycosis-endemic region and on the presence of oval, yeast-like organisms in histologic sections. However, <italic>Coccidioides immitis</italic> was never cultured from the lesion, and serologic studies for this fungus were negative. After the excision in 1997, nothing was noted further until October 1999, when a small lesion, similar in color to the original one, reappeared under the scar and gradually increased in size. The patient had no other skin lesions and was otherwise asymptomatic.</p>
    <fig id="F1" fig-type="figure" position="float">
      <label>Figure 1</label>
      <caption>
        <p>Photomicrograph of keloidal skin lesion on patient&#x2019;s right upper arm.</p>
      </caption>
      <graphic xlink:href="03-0416-F1"/>
    </fig>
    <p>The patient had spent time doing geologic work in various tropical regions over a 7-year period. In 1992&#x2013;1993, she traveled to the Four Corners region of the United States as well as to California, northern Mexico, and Costa Rica. She lived and worked in the jungles of Guyana and Venezuela for 2 years (1993 and 1994), spending most of her time around the Cuyuni, Essequibo, and Rupununi River areas, although she also spent some time in the Bolivar state of Venezuela. Thereafter, she traveled to Kazakhstan, Indonesia (Irian Jaya), and the Philippines (1995 to 1996). During her time in South America, she lived mainly in rural camps and had extensive exposure to freshwater, soil, and underground caves. Health problems encountered during her travels included dengue fever, amebic dysentery, and intestinal helminthiasis. Of note, she had never traveled to the African continent.</p>
    <p>Her medical history was otherwise unremarkable. Family history was positive for hypothyroidism. She was a nonsmoker and a social alcohol drinker. She was on hormone replacement therapy but no other medications and had no known allergies. Review of systems was unremarkable. Other than the lesion on her right arm, results of physical examination were normal.</p>
    <p>Biopsied tissue specimens of the lesion were obtained and submitted for pathologic and microbiologic examination. The hematoxylin- and eosin-stained tissue sections showed a diffuse, superficial, and deep granulomatous dermatitis with multinucleated giant cells. Intracellular and extracellular unstained fungal cells with thick refractile walls were seen, giving a &#x201C;sieve-like&#x201D; pattern to the granulomatous inflammation. The fungal cells stained strongly with periodic acid-Schiff and Grocott methenamine silver stains (<xref ref-type="fig" rid="F2">Figure 2</xref>); cells were spherical or lemon-shaped, approximately 10 &#x3BC;m in diameter, and uniform in size. They were arranged as single cells or in short budding chains joined by narrow, tubelike bridges. Calcofluor white stain (<xref ref-type="fig" rid="F3">Figure 3</xref>) of fresh tissue indicated fluorescent, spherical fungal organisms similarly arranged in chains. The organisms were not cultivatable. Fungal morphology was consistent with <italic>Loboa loboi</italic>. The lesion was completely excised with no subsequent recurrence.</p>
    <fig id="F2" fig-type="figure" position="float">
      <label>Figure 2</label>
      <caption>
        <p>Grocott methenamine silver&#x2013;stained section of skin biopsy specimen revealing a short chain of lemon-shaped fungal cells connected by thin, tubelike bridges. Morphology is consistent with the appearance of <italic>Loboa loboi</italic>. Magnification x1,000.</p>
      </caption>
      <graphic xlink:href="03-0416-F2"/>
    </fig>
    <fig id="F3" fig-type="figure" position="float">
      <label>Figure 3</label>
      <caption>
        <p>Calcofluor white stain of skin biopsy specimen. A short chain of lemon-shaped fungal cells is seen in the left-center of the field. Cells are connected to each other by thin, tubelike structures. Magnification x400.</p>
      </caption>
      <graphic xlink:href="03-0416-F3"/>
    </fig>
    <sec sec-type="">
      <title>Discussion</title>
      <p>Lobomycosis is a chronic granulomatous infection of the skin and subcutaneous tissues caused by the fungus <italic>L.</italic> <italic>loboi</italic> (<xref ref-type="bibr" rid="R1"><italic>1</italic></xref>,<xref ref-type="bibr" rid="R2"><italic>2</italic></xref>). It is characterized by the appearance of slowly developing (months, years, or decades), keloid-like, ulcerated, or verrucous nodular or plaque-like cutaneous lesions (<xref ref-type="bibr" rid="R1"><italic>1</italic></xref>,<xref ref-type="bibr" rid="R2"><italic>2</italic></xref>), usually at a site of local trauma such as from a cut, insect bite, animal bite, or ray sting (<xref ref-type="bibr" rid="R1"><italic>1</italic></xref>&#x2013;<xref ref-type="bibr" rid="R3"><italic>3</italic></xref>). Lesions may be single or multiple and tend to occur on exposed, cooler areas of the body, particularly the extremities and ears (<xref ref-type="bibr" rid="R1"><italic>1</italic></xref>,<xref ref-type="bibr" rid="R2"><italic>2</italic></xref>,<xref ref-type="bibr" rid="R4"><italic>4</italic></xref>). Other sites such as the forehead, face, chest, scapula, lumbosacral spine, buttocks, and scrotum have also been reportedly involved (<xref ref-type="bibr" rid="R2"><italic>2</italic></xref>&#x2013;<xref ref-type="bibr" rid="R7"><italic>7</italic></xref>). Mucous membranes or internal organs are not involved (<xref ref-type="bibr" rid="R2"><italic>2</italic></xref>,<xref ref-type="bibr" rid="R3"><italic>3</italic></xref>). Lesions may be nonpigmented, hypopigmented, or hyperpigmented and are usually painless or only slightly pruritic (<xref ref-type="bibr" rid="R1"><italic>1</italic></xref>,<xref ref-type="bibr" rid="R3"><italic>3</italic></xref>,<xref ref-type="bibr" rid="R4"><italic>4</italic></xref>). Little if any local host inflammatory response and no systemic symptoms exist (<xref ref-type="bibr" rid="R3"><italic>3</italic></xref>,<xref ref-type="bibr" rid="R4"><italic>4</italic></xref>). In some cases, lesions may spread contiguously or through lymphatic channels, causing cosmetic disfigurement (<xref ref-type="bibr" rid="R2"><italic>2</italic></xref>,<xref ref-type="bibr" rid="R4"><italic>4</italic></xref>,<xref ref-type="bibr" rid="R5"><italic>5</italic></xref>).</p>
      <p>On histologic examination, the lesions are composed of dermal granulomas with multinucleated giant cells filled with spherical or lemon-shaped fungal cells 6&#x2013;12 &#x3BC;m in diameter with doubly refractile walls that are commonly arranged in chains of budding cells connected by thin, tube-like bridges (<xref ref-type="bibr" rid="R1"><italic>1</italic></xref>,<xref ref-type="bibr" rid="R2"><italic>2</italic></xref>,<xref ref-type="bibr" rid="R6"><italic>6</italic></xref>,<xref ref-type="bibr" rid="R8"><italic>8</italic></xref>). <italic>Loboa loboi</italic> has never been cultivated in vitro (<xref ref-type="bibr" rid="R1"><italic>1</italic></xref>,<xref ref-type="bibr" rid="R2"><italic>2</italic></xref>), although it has been successfully transmitted to armadillos, tortoises, and the footpads of hamsters and mice under experimental conditions (<xref ref-type="bibr" rid="R2"><italic>2</italic></xref>,<xref ref-type="bibr" rid="R6"><italic>6</italic></xref>).</p>
      <p>Natural disease has been described only in humans and in marine and freshwater dolphins (<xref ref-type="bibr" rid="R1"><italic>1</italic></xref>,<xref ref-type="bibr" rid="R2"><italic>2</italic></xref>). Lobomycosis was first described by the dermatologist Jorge Lobo in 1931 (<xref ref-type="bibr" rid="R2"><italic>2</italic></xref>&#x2013;<xref ref-type="bibr" rid="R4"><italic>4</italic></xref>,<xref ref-type="bibr" rid="R9"><italic>9</italic></xref>). His patient was a 52-year-old man who worked as a rubber collector in the Amazonas state of Brazil, who had numerous slowly developing nodular keloidal lesions in the lumbosacral spine area, from which microorganisms resembling <italic>Paracoccidioides brasiliensis</italic> were observed on microscopy (<xref ref-type="bibr" rid="R2"><italic>2</italic></xref>). Lobo suspected that the patient had a modified form of paracoccidioidomycosis, which he called keloidal blastomycosis (<xref ref-type="bibr" rid="R2"><italic>2</italic></xref>). A second human case was reported in 1938, after which the disease was termed Lobo&#x2019;s disease (<xref ref-type="bibr" rid="R2"><italic>2</italic></xref>). More than 500 human cases have been reported to date (<xref ref-type="bibr" rid="R3"><italic>3</italic></xref>), although the disease appears to be confined to remote tropical areas of South and Central America, especially in communities along rivers (<xref ref-type="bibr" rid="R1"><italic>1</italic></xref>&#x2013;<xref ref-type="bibr" rid="R3"><italic>3</italic></xref>). The natural habitat of the fungus is not known but is believed to be aquatic or associated with soil and vegetation (<xref ref-type="bibr" rid="R2"><italic>2</italic></xref>,<xref ref-type="bibr" rid="R3"><italic>3</italic></xref>). Rubber workers, farmers, miners, fishermen, and hunters are particularly at risk due to extensive outdoor exposure (<xref ref-type="bibr" rid="R2"><italic>2</italic></xref>&#x2013;<xref ref-type="bibr" rid="R4"><italic>4</italic></xref>). The condition has been described in Bolivia, Brazil, Colombia, Costa Rica, Ecuador, French Guiana, Guyana, Mexico, Panama, Peru, Suriname, and Venezuela (<xref ref-type="bibr" rid="R2"><italic>2</italic></xref>&#x2013;<xref ref-type="bibr" rid="R4"><italic>4</italic></xref>).</p>
      <p>The first report of nonhuman infection occurred in 1971 in an Atlantic bottle-nosed dolphin from Florida (<xref ref-type="bibr" rid="R10"><italic>10</italic></xref>). In 1973, a dolphin with Lobo&#x2019;s disease was described in Europe along the Atlantic coast of France and Spain (<xref ref-type="bibr" rid="R11"><italic>11</italic></xref>). The dolphin&#x2019;s caretaker, a resident of Holland, later acquired the disease, the first human case of lobomycosis reported outside of Latin America (<xref ref-type="bibr" rid="R11"><italic>11</italic></xref>). Other cases of lobomycosis in dolphins have been confirmed, including one in a dolphin off the Texas coast (<xref ref-type="bibr" rid="R2"><italic>2</italic></xref>,<xref ref-type="bibr" rid="R12"><italic>12</italic></xref>).</p>
      <p>Cases of imported human lobomycosis have been described in the United States and elsewhere (<xref ref-type="bibr" rid="R6"><italic>6</italic></xref>,<xref ref-type="bibr" rid="R7"><italic>7</italic></xref>,<xref ref-type="bibr" rid="R13"><italic>13</italic></xref>,<xref ref-type="bibr" rid="R14"><italic>14</italic></xref>). A case of lobomycosis involving the chest was recently described in an Atlanta, Georgia, man who had previously traveled to Venezuela and was exposed to extremely high water pressure while walking under Angel Falls (<xref ref-type="bibr" rid="R7"><italic>7</italic></xref>), although the first published description of a human case in the United States appears to be in an immigrant from Suriname (<xref ref-type="bibr" rid="R6"><italic>6</italic></xref>). Recently, cases of imported human lobomycosis were reported in France (<xref ref-type="bibr" rid="R13"><italic>13</italic></xref>) and Germany (<xref ref-type="bibr" rid="R14"><italic>14</italic></xref>). Other imported cases in industrialized countries are believed to occur but may be misdiagnosed due to physician unfamiliarity with the disease. As far as we are aware, our report is the first of human lobomycosis in Canada. The disease was presumably acquired in Guyana or Venezuela, because her visits to Mexico and Costa Rica were unlikely to put her at risk for infection.</p>
      <p>Based on our patient&#x2019;s history, the physical findings, and the histologic appearance of the skin lesion, the diagnosis of lobomycosis was unequivocally made. Although other fungi may resemble <italic>L. loboi</italic> microscopically, including <italic>P. brasiliensis</italic>, <italic>Blastomyces dermatitidis</italic>, and <italic>Histoplasma capsulatum</italic> var <italic>dubiosii</italic> (the cause of African histoplasmosis), none of them form the characteristic chains of fungal cells of uniform size, 6- to 12-&#x3BC;m in diameter, connected by thin tubelike isthmuses, the hallmark of lobomycosis (<xref ref-type="bibr" rid="R8"><italic>8</italic></xref>). Furthermore, unlike <italic>L. loboi</italic>, the other fungi can be grown in vitro on routine mycologic media (<xref ref-type="bibr" rid="R2"><italic>2</italic></xref>,<xref ref-type="bibr" rid="R8"><italic>8</italic></xref>). In contrast to <italic>L. loboi</italic>, the mother cell of <italic>P. brasiliensis</italic> forms multiple buds and remains larger than the daughter cells, giving the characteristic &#x201C;ship&#x2019;s wheel&#x201D; appearance (<xref ref-type="bibr" rid="R1"><italic>1</italic></xref>,<xref ref-type="bibr" rid="R15"><italic>15</italic></xref>,<xref ref-type="bibr" rid="R16"><italic>16</italic></xref>). In addition, paracoccidioidomycosis is a disease of the oronasal mucous membranes and lungs (<xref ref-type="bibr" rid="R1"><italic>1</italic></xref>,<xref ref-type="bibr" rid="R16"><italic>16</italic></xref>). In contrast to <italic>B. dermatididis</italic>, the fungal cells of <italic>L. loboi</italic> do not form broad-based buds (<xref ref-type="bibr" rid="R8"><italic>8</italic></xref>). Because the patient had never traveled to Africa, she was not at risk for African histoplasmosis. Other conditions that may clinically resemble lobomycosis include keloids, leprosy, leishmaniasis, chromoblastomycosis, and malignancy (<xref ref-type="bibr" rid="R2"><italic>2</italic></xref>,<xref ref-type="bibr" rid="R4"><italic>4</italic></xref>).</p>
      <p>Lobomycosis does not usually affect the general health of a person. However, unless lesions are removed at an early stage, the disease persists for life (<xref ref-type="bibr" rid="R2"><italic>2</italic></xref>). Rarely, squamous cell carcinoma may develop from lobomycotic lesions (<xref ref-type="bibr" rid="R2"><italic>2</italic></xref>,<xref ref-type="bibr" rid="R17"><italic>17</italic></xref>).</p>
      <p>Successful treatment of lobomycosis usually consists of total surgical excision of the lesion, preferably with wide margins (<xref ref-type="bibr" rid="R1"><italic>1</italic></xref>,<xref ref-type="bibr" rid="R2"><italic>2</italic></xref>,<xref ref-type="bibr" rid="R9"><italic>9</italic></xref>), although adjunctive medical therapy with clofazamine or other agents has sometimes been used in patients with extensive disease, with limited success (<xref ref-type="bibr" rid="R2"><italic>2</italic></xref>). However, a German patient with lobomycosis had complete clinical and histopathologic resolution of disease after a 1-year treatment course of oral clofazamine and itraconazole (<xref ref-type="bibr" rid="R14"><italic>14</italic></xref>). One dolphin with Lobo&#x2019;s disease was successfully treated with miconzaole (<xref ref-type="bibr" rid="R2"><italic>2</italic></xref>). Our patient has remained disease-free for more than 2 years after surgical excision of her lobomycotic lesion.</p>
      <p>The nomenclature of the fungus has been subject to ongoing debate, although a new genus, <italic>Lacazia</italic>, with <italic>Lacazia loboi</italic> as the type species, was recently proposed by Toborda et al. (<xref ref-type="bibr" rid="R16"><italic>16</italic></xref>) and appears to be taxonomically valid. The definitive taxonomic status of this fungus awaits in vitro culture and subsequent molecular studies, although phylogenetic analysis of 18S small-subunit rDNA molecules indicates that <italic>L. loboi</italic> is a distinct and novel species phylogenetically close to but fundamentally different from <italic>P. brasiliensis</italic> (<xref ref-type="bibr" rid="R15"><italic>15</italic></xref>).</p>
      <p>In summary, lobomycosis is a slowly progressive, chronic, fungal infection of the dermis that is rarely seen in industrialized countries. This disease should be suspected in patients with single or multiple keloidal skin lesions, particularly if they have traveled to remote areas of Latin America.</p>
    </sec>
  </body>
  <back>
    <fn-group>
      <fn fn-type="citation">
        <p><italic>Suggested citation for this article:</italic> Elsayed S, Kuhn SM, Barber D, Church DL, Adams S, Kasper R. A human case of lobomycosis. Emerg Infect Dis [serial online] 2004 Apr [<italic>date cited</italic>]. Available from: <ext-link ext-link-type="uri" xlink:href="http://www.cdc.gov/ncidod/EID/vol10no4/03-0416.htm">http://www.cdc.gov/ncidod/EID/vol10no4/03-0416.htm</ext-link></p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgment</title>
      <p>We thank Martin Trotter for taking digital photographs of our pathology slides.</p>
    </ack>
    <bio>
      <p>Dr. Elsayed is an associate medical microbiologist for the Medical Staff of Calgary Laboratory Services. He is also an assistant professor of Pathology and Laboratory Medicine and Microbiology and Infectious Diseases at the University of Calgary. His current interests focus on the development of molecular assays to detect and characterize microorganisms and on fungal and mycobacterial infections.</p>
    </bio>
    <ref-list>
      <title>References</title>
      <ref id="R1">
        <label>1. </label>
        <mixed-citation publication-type="book"><string-name><surname>Hay</surname> <given-names>RJ</given-names></string-name> Cutaneous and subcutaneous mycoses. In: Anaissie EJ, McGinnis MR, Pfaller MA, editors. Clinical mycology. 1st ed. Philadelphia: Churchill Livingstone; <year>2003</year> p. 456&#x2013;73.</mixed-citation>
      </ref>
      <ref id="R2">
        <label>2. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Lobomycosis</surname> <given-names>R-TG</given-names></string-name> <source>Int J Dermatol</source>. <year>1993</year>;<volume>32</volume>:<fpage>324</fpage>&#x2013;<lpage>32</lpage> <pub-id pub-id-type="doi">10.1111/j.1365-4362.1993.tb01466.x</pub-id><pub-id pub-id-type="pmid">8505156</pub-id></mixed-citation>
      </ref>
      <ref id="R3">
        <label>3. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Fuchs</surname> <given-names>J</given-names></string-name>, <string-name><surname>Milbradt</surname> <given-names>R</given-names></string-name>, <string-name><surname>Pecher</surname> <given-names>SA</given-names></string-name> <article-title>Lobomycosis (keloidal blastomycosis): case reports and overview.</article-title> <source>Cutis</source>. <year>1990</year>;<volume>46</volume>:<fpage>227</fpage>&#x2013;<lpage>34</lpage><pub-id pub-id-type="pmid">2225930</pub-id></mixed-citation>
      </ref>
      <ref id="R4">
        <label>4. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Brun</surname> <given-names>AM</given-names></string-name> <article-title>Lobomycosis in three Venezuelan patients.</article-title> <source>Int J Dermatol</source>. <year>1999</year>;<volume>38</volume>:<fpage>302</fpage>&#x2013;<lpage>5</lpage> <pub-id pub-id-type="doi">10.1046/j.1365-4362.1999.00676.x</pub-id><pub-id pub-id-type="pmid">10321950</pub-id></mixed-citation>
      </ref>
      <ref id="R5">
        <label>5. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Rodriguez-Toro</surname> <given-names>G</given-names></string-name>, <string-name><surname>Tellez</surname> <given-names>N</given-names></string-name> <article-title>Lobomycosis in Colombian Amer Indian patients.</article-title> <source>Mycopathologia</source>. <year>1992</year>;<volume>120</volume>:<fpage>5</fpage>&#x2013;<lpage>9</lpage> <pub-id pub-id-type="doi">10.1007/BF00578495</pub-id><pub-id pub-id-type="pmid">1480207</pub-id></mixed-citation>
      </ref>
      <ref id="R6">
        <label>6. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Nalovic</surname> <given-names>K</given-names></string-name>, <string-name><surname>Pradinaud</surname> <given-names>RA</given-names></string-name> <article-title>Anergic cutaneous leishmaniasis versus lobomycosis.</article-title> <source>Int J Dermatol</source>. <year>1996</year>;<volume>35</volume>:<fpage>438</fpage>&#x2013;<lpage>40</lpage> <pub-id pub-id-type="doi">10.1111/j.1365-4362.1996.tb03028.x</pub-id><pub-id pub-id-type="pmid">8737881</pub-id></mixed-citation>
      </ref>
      <ref id="R7">
        <label>7. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Burns</surname> <given-names>RA</given-names></string-name>, <string-name><surname>Roy</surname> <given-names>JS</given-names></string-name>, <string-name><surname>Woods</surname> <given-names>C</given-names></string-name>, <string-name><surname>Padhye</surname> <given-names>AA</given-names></string-name>, <string-name><surname>Warnock</surname> <given-names>DW</given-names></string-name> <article-title>Report of the first human case of lobomycosis in the United States.</article-title> <source>J Clin Microbiol</source>. <year>2000</year>;<volume>38</volume>:<fpage>1283</fpage>&#x2013;<lpage>5</lpage><pub-id pub-id-type="pmid">10699043</pub-id></mixed-citation>
      </ref>
      <ref id="R8">
        <label>8. </label>
        <mixed-citation publication-type="book"><string-name><surname>Woods</surname> <given-names>GL</given-names></string-name>, <string-name><surname>Schnadig</surname> <given-names>VJ</given-names></string-name> Histopathology of fungal infections. In: Anaissie EJ, McGinnis MR, Pfaller MA, editors. Clinical mycology. 1st ed. Philadelphia: Churchill Livingstone; <year>2003</year> p. 80&#x2013;95.</mixed-citation>
      </ref>
      <ref id="R9">
        <label>9. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Baruzzi</surname> <given-names>RG</given-names></string-name>, <string-name><surname>Marcopito</surname> <given-names>LF</given-names></string-name>, <string-name><surname>Michalany</surname> <given-names>NS</given-names></string-name>, <string-name><surname>Livianu</surname> <given-names>J</given-names></string-name>, <string-name><surname>Pinto</surname> <given-names>NR</given-names></string-name> <article-title>Early diagnosis and prompt treatment by surgery in Jorge Lobo&#x2019;s disease (keloidal blastomycosis).</article-title> <source>Mycopathologia</source>. <year>1981</year>;<volume>74</volume>:<fpage>51</fpage>&#x2013;<lpage>4</lpage> <pub-id pub-id-type="doi">10.1007/BF00441441</pub-id><pub-id pub-id-type="pmid">7242649</pub-id></mixed-citation>
      </ref>
      <ref id="R10">
        <label>10. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Migaki</surname> <given-names>G</given-names></string-name>, <string-name><surname>Valerio</surname> <given-names>MG</given-names></string-name>, <string-name><surname>Irvine</surname> <given-names>B</given-names></string-name>, <string-name><surname>Garner</surname> <given-names>FM</given-names></string-name> <article-title>Lobo&#x2019;s disease in an atlantic bottle-nosed dolphin.</article-title> <source>J Am Vet Med Assoc</source>. <year>1971</year>;<volume>159</volume>:<fpage>578</fpage>&#x2013;<lpage>82</lpage><pub-id pub-id-type="pmid">5106378</pub-id></mixed-citation>
      </ref>
      <ref id="R11">
        <label>11. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Symmers</surname> <given-names>WS</given-names></string-name> <article-title>A possible case of Lobo&#x2019;s disease acquired in Europe from a bottle-nosed dolphin (<italic>Tursiops truncatus</italic>).</article-title> <source>Bull Soc Pathol Exot</source>. <year>1983</year>;<volume>76</volume>:<fpage>777</fpage>&#x2013;<lpage>84</lpage><pub-id pub-id-type="pmid">6231133</pub-id></mixed-citation>
      </ref>
      <ref id="R12">
        <label>12. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Cowan</surname> <given-names>DF</given-names></string-name> <article-title>Lobo&#x2019;s disease in a bottlenose dolphin (<italic>Tursiops truncatus</italic>) from Matagorda Bay, Texas.</article-title> <source>J Wildl Dis</source>. <year>1993</year>;<volume>29</volume>:<fpage>488</fpage>&#x2013;<lpage>9</lpage><pub-id pub-id-type="pmid">8355355</pub-id></mixed-citation>
      </ref>
      <ref id="R13">
        <label>13. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Saint-Blancard</surname> <given-names>P</given-names></string-name>, <string-name><surname>Maccari</surname> <given-names>F</given-names></string-name>, <string-name><surname>Le Guyadec</surname> <given-names>T</given-names></string-name>, <string-name><surname>Lanternier</surname> <given-names>G</given-names></string-name>, <string-name><surname>Le Vagueresse</surname> <given-names>R</given-names></string-name> <article-title>Lobomycosis: a mycosis seldom observed in metropolitan France.</article-title> <source>Ann Pathol</source>. <year>2000</year>;<volume>20</volume>:<fpage>241</fpage>&#x2013;<lpage>4</lpage><pub-id pub-id-type="pmid">10891722</pub-id></mixed-citation>
      </ref>
      <ref id="R14">
        <label>14. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Fischer</surname> <given-names>M</given-names></string-name>, <string-name><surname>Chrusciak-Talhari</surname> <given-names>A</given-names></string-name>, <string-name><surname>Reinel</surname> <given-names>D</given-names></string-name>, <string-name><surname>Talhari</surname> <given-names>S</given-names></string-name> <article-title>Successful treatment with clofazimine and itraconazole in a 46 year old patient after 32 years duration of disease.</article-title> <source>Hautarzt</source>. <year>2002</year>;<volume>53</volume>:<fpage>677</fpage>&#x2013;<lpage>81</lpage> <pub-id pub-id-type="doi">10.1007/s00105-002-0351-y</pub-id><pub-id pub-id-type="pmid">12297950</pub-id></mixed-citation>
      </ref>
      <ref id="R15">
        <label>15. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Herr</surname> <given-names>RA</given-names></string-name>, <string-name><surname>Tarch</surname> <given-names>EJ</given-names></string-name>, <string-name><surname>Taborda</surname> <given-names>PR</given-names></string-name>, <string-name><surname>Taylor</surname> <given-names>JW</given-names></string-name>, <string-name><surname>Ajello</surname> <given-names>L</given-names></string-name>, <string-name><surname>Mendoza</surname> <given-names>L</given-names></string-name> <article-title>Phylogenetic analysis of <italic>Lacazia loboi</italic> places this previously uncharacterized pathogen within the dimorphic onygenales.</article-title> <source>J Clin Microbiol</source>. <year>2001</year>;<volume>39</volume>:<fpage>309</fpage>&#x2013;<lpage>14</lpage> <pub-id pub-id-type="doi">10.1128/JCM.39.1.309-314.2001</pub-id><pub-id pub-id-type="pmid">11136789</pub-id></mixed-citation>
      </ref>
      <ref id="R16">
        <label>16. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Taborda</surname> <given-names>PR</given-names></string-name>, <string-name><surname>Taborda</surname> <given-names>VA</given-names></string-name>, <string-name><surname>McGinnis</surname> <given-names>R</given-names></string-name> <article-title><italic>Lacazia loboi</italic> gen. nov., comb. nov., the etiologic agent of lobomycosis.</article-title> <source>J Clin Microbiol</source>. <year>1999</year>;<volume>37</volume>:<fpage>2031</fpage>&#x2013;<lpage>3</lpage><pub-id pub-id-type="pmid">10325371</pub-id></mixed-citation>
      </ref>
      <ref id="R17">
        <label>17. </label>
        <mixed-citation publication-type="journal"><string-name><surname>Baruzzi</surname> <given-names>RG</given-names></string-name>, <string-name><surname>Rodrigues</surname> <given-names>DA</given-names></string-name>, <string-name><surname>Michalany</surname> <given-names>NS</given-names></string-name>, <string-name><surname>Salamao</surname> <given-names>R</given-names></string-name> <article-title>Squamous-cell carcinoma and lobomycosis (Jorge Lobo&#x2019;s disease).</article-title> <source>Int J Dermatol</source>. <year>1989</year>;<volume>28</volume>:<fpage>183</fpage>&#x2013;<lpage>5</lpage> <pub-id pub-id-type="doi">10.1111/j.1365-4362.1989.tb02459.x</pub-id><pub-id pub-id-type="pmid">2707943</pub-id></mixed-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
